Literature DB >> 15278326

Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats.

H Parlakpinar1, M Koc, A Polat, N Vardi, M K Ozer, Y Turkoz, A Acet.   

Abstract

Aminoglycoside antibiotics have long been used in antibacterial therapy. Despite their beneficial effects, aminoglycosides have considerable nephrotoxic and ototoxic side effects. It has been reported that reactive oxygen radical species (ROS) play role in the pathophysiology of aminoglycosides-induced nephrotoxicity. Aminoguanidine (AG) is an effective antioxidant and free radical scavenger which has long been known to protect against nephrotoxicity. We investigated the effects of AG on amikacin (AK)-induced changes of renal malondialdehyde (MDA), glutathione (GSH), blood urea nitrogen (BUN), serum creatinine (Cr) and albumin (Alb) which are used to monitor the development of renal tubular damage. Morphological changes in the kidney were also examined using light microscopy. A total of 21 rats were equally divided into three groups which were: (1) injected with saline, (2) injected with AK, and (3) injected with AK + AG, respectively. AK administration to control rats increased renal MDA and decreased GSH levels. AG administration before AK injection caused significant decreases in MDA and increases in GSH levels in kidneys compared to rats treated with AK alone. The serum BUN level increased slightly, Cr and serum Alb did not change as a result of any treatment. AG tended to decrease the level of serum BUN and did not cause any change in Alb or Cr levels. Morphological changes, including glomerular, tubular epithelial alterations and interstitial edema, were clearly observed in AK-treated rats. In addition, AG reversed the morphological damage to the kidney induced by AK. The results show that AG has a protective effect on nephrotoxicity induced by AK and may therefore improve the therapeutic index of AK. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278326     DOI: 10.1007/s00240-004-0399-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Inhibitory effects of aminoglycosides on renal protein phosphorylation by protein kinase C.

Authors:  M Hagiwara; M Inagaki; K Kanamura; H Ohta; H Hidaka
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

2.  Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats.

Authors:  K Sugimoto; S Yagihashi
Journal:  Microvasc Res       Date:  1997-03       Impact factor: 3.514

3.  Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats.

Authors:  S H Ihm; H J Yoo; S W Park; J Ihm
Journal:  Metabolism       Date:  1999-09       Impact factor: 8.694

4.  Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.

Authors:  J M Prins; G J Weverling; K de Blok; R J van Ketel; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury.

Authors:  Hakan Parlakpinar; Engin Sahna; M K Ozer; Fikret Ozugurlu; Nigar Vardi; Ahmet Acet
Journal:  J Pineal Res       Date:  2002-10       Impact factor: 13.007

6.  Amikacin-induced acute renal injury in rats: protective role of melatonin.

Authors:  Hakan Parlakpinar; M K Ozer; Engin Sahna; Nigar Vardi; Yilmaz Cigremis; Ahmet Acet
Journal:  J Pineal Res       Date:  2003-09       Impact factor: 13.007

7.  Comparison of methods for prediction of nephrotoxicity during development.

Authors:  J Klein; G Koren; S M MacLeod
Journal:  Dev Pharmacol Ther       Date:  1992

8.  Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.

Authors:  I Giardino; A K Fard; D L Hatchell; M Brownlee
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

9.  Urinary phospholipids excretion in neonates treated with amikacin.

Authors:  S Ibrahim; J P Langhendries; A Bernard; P M Tulkens
Journal:  Int J Clin Pharmacol Res       Date:  1994

10.  The role of lipid peroxidation in the nephrotoxicity of cisplatin.

Authors:  N P Vermeulen; G S Baldew
Journal:  Biochem Pharmacol       Date:  1992-09-25       Impact factor: 5.858

View more
  4 in total

1.  Section 3: Prevention and Treatment of AKI.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03

2.  Antiapoptotic effect of aminoguanidine on doxorubicin-induced apoptosis.

Authors:  Suna Sabuncuoglu
Journal:  Mol Cell Biochem       Date:  2014-05-17       Impact factor: 3.396

3.  Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.

Authors:  Binish Arif; Zarina Arif; Jamal Ahmad; Kahkashan Perveen; Najat A Bukhari; Jalaluddin M Ashraf; Khursheed Alam
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.240

4.  Beneficial effects of aminoguanidine on skin flap survival in diabetic rats.

Authors:  Ayse Ozturk; Cemal Fırat; Hakan Parlakpınar; Aysun Bay-Karabulut; Hale Kirimlioglu; Ali Gurlek
Journal:  Exp Diabetes Res       Date:  2012-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.